Results 91 to 100 of about 47,298 (270)

Pharmacotherapy of Myasthenia Gravis

open access: yes, 2015
The pharmacotherapy of Myasthenia Gravis is gradually advancing with special regard to immunospuression.
Omar, Majeed
core  

Efficacy Evaluation of Thymectomy in Myasthenia Patients [PDF]

open access: yesСаратовский научно-медицинский журнал, 2009
The condition of 71 patients with myasthenia after thymectomy has been analyzed. Supervision has been carried out from 6 months till 9 years. Thymic hyperplasia has been marked at histological research of operational material in 46,5% of patients. Thymic
A.P. Reshetov   +3 more
doaj  

Risk Factors for Cutaneous Immune‐Related Adverse Events in the Japanese Population: A Retrospective Single‐Center Cohort Study

open access: yesThe Journal of Dermatology, EarlyView.
ABSTRACT Immune checkpoint inhibitor (ICI)‐driven alterations in the immune system can induce immune‐related adverse events (irAEs). Cutaneous irAEs are notable for being the most common and for their early onset; however, the risk factors underlying their development and severity remain unclear. In this study, we retrospectively analyzed 1224 Japanese
Tomoya Watanabe   +4 more
wiley   +1 more source

Anaesthetic Management of Myasthenia Gravis with Thymic Mass in Facial Trauma

open access: yes, 2010
Myasthenia gravis is an immunologic disorder characterised by polyclonal antibodies directed against nicotinic acetylcholine receptors at postneuromuscular junction.
Dheer Singh, Deepak Sharma
core  

Coexistence of anti-synthetase syndrome, myasthenia and scleroderma: A scarce case report [PDF]

open access: yesRomanian Journal of Rheumatology
Introduction. Polyautoimmunity refers to the phenomenon where an individual is affected by multiple autoimmune diseases simultaneously. This condition underscores the complexity of autoimmune disorders and their interconnected nature, often resulting ...
Sameh Sayhi   +5 more
doaj   +1 more source

What is the incidence and clinical significance of dry eye disease in patients treated with immune checkpoint inhibitors? A systematic review and meta‐analysis of ocular immune‐related adverse events

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose Immune checkpoint inhibitors (ICIs) have transformed cancer therapy but may cause immune‐related adverse events (irAEs), including dry eye disease (DED). This study aimed to quantify the incidence of ICI‐associated DED and to evaluate factors contributing to variability across studies.
Kai‐Yang Chen   +2 more
wiley   +1 more source

Frontalis sling procedure for ocular myasthenia gravis

open access: yes, 2012
Shinichi Asamura1, Hirohiko Kakizaki2, Mitsuhiro Enjyo1, Takahiro Hashimoto1, Noritaka Isogai11Department of Plastic and Reconstructive Surgery, Kinki University School of Medicine, Osakasayama, Osaka, Japan; 2Department of Ophthalmology, Aichi Medical ...
Hashimoto T   +4 more
core  

Alkalinised lidocaine as an anaesthetic before onabotulinumtoxinA injections. a randomised trial

open access: yesBJU International, Volume 135, Issue 4, Page 638-647, April 2025.
Objectives To evaluate the effect of intravesical alkalinised lidocaine as an anaesthetic treatment on procedural pain during intradetrusor onabotulinumtoxinA (BTX‐A) injections for overactive bladder. Patients and Methods This single‐centre, randomised, double‐blind, placebo‐controlled two period crossover trial was conducted on women scheduled for ...
Meryam El Issaoui   +2 more
wiley   +1 more source

Comparison of diagnostic tests in myasthenia gravis

open access: yes, 1983
Results of 3 tests, intravenous edrophonium chloride, EMG, and acetylcholine receptor antibody testing, were compared in patients with generalised and ocular myasthenia gravis.
Nicholson, G. A.   +2 more
core  

The combination of macromastia and myasthenia. A case report

open access: yesЭндокринная хирургия, 2014
The article presents a rare clinical observation of combination of bilateral gigantomastia with myasthenia. The debut of myasthenia dangerous to sudden respiratory failure.
Valeriy Vital'evich Voskoboynikov   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy